660
Participants
Start Date
July 31, 2011
Primary Completion Date
January 31, 2012
Study Completion Date
February 29, 2012
160Eu/0.5ml in infants (6-11 months old)
inactivated EV71 vaccine (KMB-17) of 160Eu/0.5ml in 60 infants aged 6-11 months old on day 0, 28
320Eu/0.5ml in infants (6-11 months old)
inactivated EV71 vaccine (KMB-17) of 320Eu/0.5ml in 60 infants aged 6-11 months old on day 0, 28
640Eu/0.5ml in infants (6-11 months old)
inactivated EV71 vaccine (KMB-17) of 640Eu/0.5ml in 40 infants aged 6-11 months old on day 0, 28
1280Eu/0.5ml (without adjuvant) in infants (6-11 months old)
inactivated EV71 vaccine (KMB-17) of 1280Eu/0.5ml (without adjuvant) in 40 infants aged 6-11 months old on day 0, 28
0Eu/0.5ml in infants (6-11 months old)
0Eu/0.5ml placebo in 80 infants aged 6-11 months old on day 0, 28
160Eu/0.5ml in infants (12-23 months old)
inactivated EV71 vaccine (KMB-17) of 160Eu/0.5ml in 30 infants aged 12-23 months old on day 0, 28
320Eu/0.5ml in infants (12-23 months old)
inactivated EV71 vaccine (KMB-17) of 320Eu/0.5ml in 30 infants aged 12-23 months old on day 0, 28
640Eu/0.5ml in infants (12-23 months old)
inactivated EV71 vaccine (KMB-17) of 640Eu/0.5ml in 40 infants aged 12-23 months old on day 0, 28
1280Eu/0.5ml (without adjuvant) in infants (12-23 months old)
inactivated EV71 vaccine (KMB-17) of 1280Eu/0.5ml (without adjuvant) in 40 infants aged 12-23 months old on day 0, 28
0Eu/0.5ml in infants (12-23 months old)
0Eu/0.5ml placebo in 50 infants aged 12-23 months old on day 0, 28
160Eu/0.5ml in children (24 months-5 years old)
inactivated EV71 vaccine (KMB-17) of 160Eu/0.5ml in 30 children aged 24 months-5 years months old on day 0, 28
320Eu/0.5ml in children (24 months-5 years old)
inactivated EV71 vaccine (KMB-17) of 320Eu/0.5ml in 30 children aged 24 months-5 years months old on day 0, 28
640Eu/0.5ml in children (24 months-5 years old)
inactivated EV71 vaccine (KMB-17) of 640Eu/0.5ml in 40 children aged 24 months-5 years months old on day 0, 28
1280Eu/0.5ml (without adjuvant) in children (24 months-5 years old)
inactivated EV71 vaccine (KMB-17) of 1280Eu/0.5ml in 40 children aged 24 months-5 years months old on day 0, 28
0Eu/0.5ml in children (24 months-5 years old)
0Eu/0.5ml placebo in 50 children aged 24 months-5 years old on day 0, 28
Guangxi Provincial Center for Diseases Control and Prevention, Nanning
Guangxi Center for Disease Control and Prevention
OTHER_GOV
Institute of Medical Biology, Chinese Academy of Medical Sciences
OTHER